Conclusions
Hopefully, the unprecedent efforts of clinical researchers in the fight
against the SARS Cov-2 will result into the identification of effective
treatments. This would largely counterbalance the delaying effects of
COVID-on ongoing trials for other diseases. However, these efforts might
be negatively affected in the absence of guidelines for a more
harmonized clinical research and a united commitment of the scientific
community to share personal knowledge and data. Allergists and clinical
immunologists should have a leading role in this unprecedent challenge.